ANIP vs. TMDX
ANIP (ANI Pharmaceuticals, Inc.) and TMDX (TransMedics Group, Inc.) are both stocks. Both are in the Healthcare sector — ANIP in Drug Manufacturers - Specialty & Generic, TMDX in Medical Devices. Over the past 5 years, ANIP returned 19.64%/yr vs 19.94%/yr for TMDX. At a 0.23 correlation, their price movements are largely independent.
Performance
ANIP vs. TMDX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ANIP achieves a 2.08% return, which is significantly higher than TMDX's -37.93% return.
ANIP
- 1D
- 1.37%
- 1M
- -2.59%
- YTD
- 2.08%
- 6M
- -0.17%
- 1Y
- 22.91%
- 3Y*
- 15.92%
- 5Y*
- 19.64%
- 10Y*
- 4.02%
TMDX
- 1D
- -4.16%
- 1M
- 9.54%
- YTD
- -37.93%
- 6M
- -41.62%
- 1Y
- -38.89%
- 3Y*
- -1.94%
- 5Y*
- 19.94%
- 10Y*
- —
ANIP vs. TMDX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ANIP ANI Pharmaceuticals, Inc. | 2.08% | 42.80% | 0.25% | 37.06% | -12.70% | 58.68% | -52.91% | -12.20% |
TMDX TransMedics Group, Inc. | -37.93% | 95.11% | -21.01% | 27.88% | 222.13% | -3.72% | 4.68% | -6.12% |
Correlation
The correlation between ANIP and TMDX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since May 2, 2019 | 0.23 |
Fundamentals
ANIP:
$1.74B
TMDX:
$2.73B
ANIP:
$4.26
TMDX:
$4.34
ANIP:
18.91
TMDX:
17.40
ANIP:
0.13
TMDX:
0.04
ANIP:
1.84
TMDX:
4.70
ANIP:
3.09
TMDX:
5.53
ANIP:
$923.71M
TMDX:
$635.89M
ANIP:
$486.11M
TMDX:
$375.74M
ANIP:
$234.71M
TMDX:
$125.51M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ANIP vs. TMDX — Risk / Return Rank
ANIP
TMDX
ANIP vs. TMDX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ANI Pharmaceuticals, Inc. (ANIP) and TransMedics Group, Inc. (TMDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ANIP | TMDX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.32 | ||
| Sortino ratioReturn per unit of downside risk | +2.08 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.91 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | 0.80 | -0.66 | +1.47 |
| Martin ratioReturn relative to average drawdown | 1.48 | -1.60 | +3.08 |
Loading charts...
Drawdowns
ANIP vs. TMDX - Drawdown Comparison
The maximum ANIP drawdown since its inception was -98.81%, which is greater than TMDX's maximum drawdown of -73.69%. Use the drawdown chart below to compare losses from any high point for ANIP and TMDX.
Loading charts...
Drawdown Indicators
| ANIP | TMDX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.81% | -73.69% | -25.12% |
Max Drawdown (1Y)Largest decline over 1 year | -28.66% | -58.76% | +30.10% |
Max Drawdown (3Y)Largest decline over 3 years | -28.66% | -67.79% | +39.13% |
Max Drawdown (5Y)Largest decline over 5 years | -59.38% | -67.79% | +8.41% |
Max Drawdown (10Y)Largest decline over 10 years | -72.96% | — | — |
Current DrawdownCurrent decline from peak | -82.09% | -57.12% | -24.97% |
Average DrawdownAverage peak-to-trough decline | -79.39% | -31.96% | -47.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.54% | 24.32% | -8.78% |
Volatility
ANIP vs. TMDX - Volatility Comparison
The current volatility for ANI Pharmaceuticals, Inc. (ANIP) is 9.06%, while TransMedics Group, Inc. (TMDX) has a volatility of 12.83%. This indicates that ANIP experiences smaller price fluctuations and is considered to be less risky than TMDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ANIP | TMDX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.06% | 12.83% | -3.77% |
Volatility (6M)Calculated over the trailing 6-month period | 24.48% | 44.78% | -20.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.60% | 58.24% | -22.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.33% | 72.16% | -25.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.20% | 71.72% | -23.52% |
Dividends
ANIP vs. TMDX - Dividend Comparison
Neither ANIP nor TMDX has paid dividends to shareholders.
Financials
ANIP vs. TMDX - Financials Comparison
This section allows you to compare key financial metrics between ANI Pharmaceuticals, Inc. and TransMedics Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ANIP vs. TMDX - Profitability Comparison
ANIP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 237.46M. Therefore, the gross margin over that period was 0.0%.
TMDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported a gross profit of 101.16M and revenue of 173.93M. Therefore, the gross margin over that period was 58.2%.
ANIP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported an operating income of 38.89M and revenue of 237.46M, resulting in an operating margin of 16.4%.
TMDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported an operating income of 13.30M and revenue of 173.93M, resulting in an operating margin of 7.6%.
ANIP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ANI Pharmaceuticals, Inc. reported a net income of 29.49M and revenue of 237.46M, resulting in a net margin of 12.4%.
TMDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TransMedics Group, Inc. reported a net income of 7.32M and revenue of 173.93M, resulting in a net margin of 4.2%.
Frequently Asked Questions
ANIP and TMDX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TMDX has higher volatility (12.83%) compared to ANIP (9.06%). In terms of maximum drawdown, ANIP dropped -98.81% vs TMDX's -73.69%.
ANIP currently has the higher Sharpe Ratio (0.65 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ANIP and TMDX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer